Chaoncin Sooksriwong

Dr. Chaoncin Sooksriwong


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 October 2025 in Exploratory Research in Clinical and Social Pharmacy
Verified
Journal Article
Open access
TSThunpitcha Sakpirom
Thunpitcha Sakpirom
KMKusawadee Maluangnon
Kusawadee Maluangnon
CSChaoncin Sooksriwong
Chaoncin Sooksriwong
AIApinya Ingard
Apinya Ingard
Irrational drug use remains a global health challenge, particularly in underserved communities with limited healthcare access. In Thailand, despite the Rational Drug Use (RDU) initiative, problems such as antibiotic misuse and selfmedication persist. Rational Drug Use Literacy (RDUL)—the ability to access, understand, evaluate, and apply drug information—is vital for improving medication behaviors. While most efforts focus on health professionals, the role of community leaders has been less explored. A cross-sectional study was conducted with 328 participants in Pathum Thani Province, including 168 community members and 160 community leaders selected through stratified random sampling. Data were collected using a structured questionnaire and a validated RDUL tool. Structural Equation Modeling (PLS-SEM) was used to assess direct and moderating effects of situational and socioenvironmental factors on RDUL. Community leaders exhibited higher Rational Drug Use Literacy (RDUL) than community members (M = 41.90 vs. 39.48, p = .003), particularly in accessing, appraising, and applying drug information. Structural Equation Modeling revealed that both situational factors (β = 0.357, p < .001) and socio-environmental factors (β = 0.168, p = .021) positively influenced RDUL, indicating that favorable circumstances and supportive environments enhance individuals' medication literacy. Importantly, leadership played a nuanced role: it diminished the influence of situational factors on RDUL (β = −0.634, p < .001) while moderately amplifying the effect of socioenvironmental factors (β = 0.327, p = .058). These results highlight that community leaders not only enhance overall medication literacy but also alter how contextual factors contribute to informed drug use. Community leaders play a complex but crucial role in shaping RDUL. While they strengthen certain literacy dimensions, their influence also alters contextual effects. RDUL strategies should leverage leaders as trusted figures while enhancing their capacity to promote informed medication use. Incorporating community leadership into health programs may increase the effectiveness and sustainability of RDU efforts in resource-limited settings.

Verified
Journal Article
Open access
PDF file
POPiyapat Owat
Piyapat Owat
CSChaoncin Sooksriwong
Chaoncin Sooksriwong
HRHataiwan Ratanabunjerdkul
Hataiwan Ratanabunjerdkul
TPTuangrat Phodha
Tuangrat Phodha
High-cost innovative anticancer drugs pose challenges for health systems in balancing timely patient access with long-term financial sustainability. In Thailand, reliance on Health Technology Assessment for reimbursement decisions may delay access, highlighting the potential role of Managed Entry Agreements (MEAs) as complementary policy instruments to manage uncertainty related to price, effectiveness, and use; however, MEA application remains limited and lacks an analytical framework for technique selection. This study used real-world data from Thammasat University Hospital to examine and compare the cost-saving performance of five MEA techniques—discount, free initiation treatment, utilization cap, conditional treatment continuation, and pay-by-result—across six high-cost anticancer drugs representing dominant uncertainty characteristics. Drug procurement costs were modeled over a 24-month horizon from the payer’s perspective, and one-way sensitivity analyses were conducted using ±10% variation in median progression-free survival. Free initiation treatment generated the highest cost savings across uncertainty types, followed by conditional treatment continuation, while utilization cap and discount produced more moderate savings. Pay-by-result demonstrated the lowest cost-saving potential. Sensitivity analyses confirmed the robustness of comparative rankings. Overall, the findings indicate that MEA performance varies according to dominant sources of drug-related uncertainty and support a more structured, context-appropriate approach to MEA selection to strengthen market access and value-based pricing in Thailand.